Examining muscle characteristics in colorectal cancer patients with cachexia
Official title: Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients
Run by Hasselt University · NCT06780423 · Data updated 2026-11-12
This study looks at the muscles of colorectal cancer patients with and without cachexia to see how they differ from healthy people.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Hasselt University Academic / other |
| Locations | 2 sites (Diepenbeek, Limburg and 1 other locations) |
| Status | Recruiting |
| Started | January 23, 2022 |
| Main results expected | March 15, 2025 |
| Study ends | September 10, 2025 |
| Registry record updated | September 9, 2025 |
| Trial ID | NCT06780423 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with cachexia associated with colorectal cancer.
✕Probably not a fit
Patients with mental or psychological conditions, muscle diseases affecting the spine and lower limbs, or those who are bedridden may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the structural characteristics of trunk and limb muscles in cachectic colorectal cancer patients compared to non-cachectic patients and healthy controls. The study will involve taking minimal invasive fine needle muscle biopsies from the m. erector spinae and m. vastus lateralis muscles. A total of 60 participants will be recruited, including 10 cachectic patients, 25 non-cachectic patients, and 25 healthy controls, with measurements taken at a single time point to evaluate muscle characteristics and their implications in cancer cachexia.
Why it matters
Potential benefit: If successful, this study could enhance understanding of muscle deterioration in cachectic colorectal cancer patients, potentially leading to improved management strategies.
How similar studies have gone: While studies on cachexia and muscle characteristics exist, this specific approach of comparing muscle biopsies across different patient groups is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Cachectic colorectal cancer patients. Inclusion criteria: * minimum age of 18 years old * unwanted weight loss \> 5% in the last 6 months OR \> 2% unwanted weight loss in combination with a BMI \< 20kg/m2 OR \>2% unwanted weight loss in combination with sarcopenia * Cachexia staging score (CSS): 5-12 Exclusion Criteria: * Mental of psychological condition * Insufficient knowledge of the Dutch language * Muscle diseases affecting the spine and lower limbs * Bedridden Non-Cachectic cancer patients. Inclusion criteria: * minimum age of 18 years old * No unwanted weight loss \> 5% in the last 6 months OR \> 2% unwanted weight loss in combination with a BMI \< 20kg/m2 OR \>2% unwanted weight loss in combination with sarcopenia * Cachexia staging score (CSS): 0-2 Exclusion criteria: * Mental of psychological condition * Insufficient knowledge of the Dutch language * Muscle diseases affecting the spine and lower limbs * Bedridden Healthy controls. Inclusion criteria: \- minimum age of 18 years old Exclusion criteria: * Mental of psychological condition * Insufficient knowledge of the Dutch language * Muscle diseases affecting the spine and lower limbs * Bedridden
Where it's running
-
Hasselt University - REVAL research institution
Diepenbeek, Limburg, Belgium Recruiting -
Jessa Hospital
Hasselt, Limburg, Belgium Recruiting
Study contacts
- Principal investigator: Kenneth Verboven, Professor — Hasselt University - REVAL
- Study coordinator: Britt van de Haterd, PhD student
- Email: britt.vandehaterd@uhasselt.be
- Phone: 0032479871509
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NGM120 treatment for cachexia in colorectal cancer
This trial tests whether the drug NGM120 can help people with colorectal cancer who have cancer cachexia gain or maintain weight and improve symptoms.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Liver transplantation for colorectal cancer with liver metastases
This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.